The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B
Korean J Hepatol. 2007;13(4):503-512. Published online 2007 Dec 20 DOI: https://doi.org/10.3350/kjhep.2007.13.4.503
Citations to this article as recorded by 
Carbohydrate-based drugs launched during 2000−2021
Xin Cao, Xiaojing Du, Heng Jiao, Quanlin An, Ruoxue Chen, Pengfei Fang, Jing Wang, Biao Yu
Acta Pharmaceutica Sinica B.2022; 12(10): 3783. CrossRef
Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24
Chao Wei Hsu, You Chen Chao, Chuan Mo Lee, Ting Tsung Chang, Yi Cheng Chen
BMC Gastroenterology.2012;[Epub] CrossRef
Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
Soon Sun Kim, Jae Youn Cheong, Sung Won Cho
Gut and Liver.2011; 5(3): 278. CrossRef
Telbivudine
Kate McKeage, Susan J. Keam
Drugs.2010; 70(14): 1857. CrossRef
Current status of liver diseases in Korea: Hepatitis B
Hee Bok Chae, Jong-Hyun Kim, Ja Kyung Kim, Hyung Joon Yim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S13. CrossRef
Management of Chronic Hepatitis B
Kwan Sik Lee, Dong Joon Kim
The Korean Journal of Hepatology.2007; 13(4): 447. CrossRef